Author/Authors :
Prassopoulos, Vassilios SA Hygeia Hospital - Clinic of Nuclear Medicine and PET/CT - Athens, Greece , Nikaki, Alexandra SA Hygeia Hospital - Clinic of Nuclear Medicine and PET/CT - Athens, Greece , Vlachou, Fani SA Hygeia Hospital - Clinic of Nuclear Medicine and PET/CT - Athens, Greece , Dalianis, Konstantinos SA Hygeia Hospital - Clinic of Nuclear Medicine and PET/CT - Athens, Greece , Gogos, Konstantinos SA Hygeia Hospital - Clinic of Nuclear Medicine and PET/CT - Athens, Greece , Alexopoulos, Athanasios SA Hygeia Hospital - Clinic of Pathology and Oncology - Athens, Greece , Rapti, Vasiliki SA Hygeia Hospital - Clinic of Pathology and Oncology - Athens, Greece , Filippi, Vasiliki SA Hygeia Hospital - Clinic of Radiology and PET/CT - Athens, Greece , Andreou, Ioannis SA Hygeia Hospital - Clinic of Radiology and PET/CT - Athens, Greece , Efthymiadou, Roxani SA Hygeia Hospital - Clinic of Radiology and PET/CT - Athens, Greece
Abstract :
The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to benign conditions, may actually represent active disease. Such an example of calcified formations is psammoma bodies. We present a case of 56-y. o. patient with ovarian cancer relapse at the supraclavicular area 18 years after complete response and disease-free interval. The patient received chemotherapy and underwent 18F-FDG-PET/CT for the evaluation of treatment response. Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease.
